Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant

H Takahashi, Y Nakagawa, CD Pendleton… - Science, 1992 - science.org
H Takahashi, Y Nakagawa, CD Pendleton, RA Houghten, K Yokomuro, RN Germain…
Science, 1992science.org
An immunodominant determinant for cytotoxic T lymphocytes (CTLs) exists in the
hypervariable portion of human immunodeficiency virus-1 (HIV-1) gp160. Three mouse CTL
lines (specific for isolates MN, RF, and IIIB) were examined for recognition of homologous
determinants from distinct isolates. Only MN-elicited CTLs showed extensive interisolate
cross-reactivity. Residue 325 played a critical role in specificity, with MN-elicited CTLs
responding to peptides with an aromatic or cyclic residue and IIIB-induced cells recognizing …
An immunodominant determinant for cytotoxic T lymphocytes (CTLs) exists in the hypervariable portion of human immunodeficiency virus-1 (HIV-1) gp160. Three mouse CTL lines (specific for isolates MN, RF, and IIIB) were examined for recognition of homologous determinants from distinct isolates. Only MN-elicited CTLs showed extensive interisolate cross-reactivity. Residue 325 played a critical role in specificity, with MN-elicited CTLs responding to peptides with an aromatic or cyclic residue and IIIB-induced cells recognizing peptides with an aliphatic residue at this position. CTL populations with broad specificities were generated by restimulation of IIIB-gp160 primed cells with MN-type peptides that have an aliphatic substitution at 325. This represents an approach to synthetic vaccines that can generate broadly cross-reactive CTLs capable of effector function against a wide range of HIV isolates.
AAAS